🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of inhaled...
Status
Completed
Location
Pivotal Research Centers
Start Date
2009-03
Trial ID
NCT00871182
Treatments Being Tested
The primary objective is to compare the efficacy of UMEC/VI Inhalation Powd...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-15
Trial ID
NCT01899742
Treatments Being Tested
The primary objective of this study is to assess and compare the pharmacoki...
Status
Completed
Location
Teva Investigational Site 32170
Start Date
2013-01
Trial ID
NCT01785433
The purpose of this study is to investigate the effect of combined treatmen...
Status
Completed
Location
Research Site
Start Date
2007-05
Trial ID
NCT00496470
Treatments Being Tested
This study is to characterize the pharmacodynamic characteristics and to as...
Status
Completed
Location
Investigational Site 203
Start Date
2022-03-24
Trial ID
NCT05161156
The purpose of this study is to determine the triple combination of beclome...
Status
Completed
Location
Institut für klinische Forschung
Start Date
2014-01
Trial ID
NCT01911364
Treatments Being Tested
Chronic obstructive pulmonary disease (COPD) is one of the commonest respir...
Status
Completed
Location
Beijing Chao-Yang Hospital
Start Date
2011-11
Trial ID
NCT01455129
Treatments Being Tested
To demonstrate that tiotropium (Spiriva®) does not prolong the QT interval ...
Status
Completed
Location
Humanpharmakologisches Zentrum
Start Date
2004-10
Trial ID
NCT00257452
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
The purpose of this study is to evaluate the effects on lung function of a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02
Trial ID
NCT01751113